GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) » Definitions » Inventories, Raw Materials & Components

Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Inventories, Raw Materials & Components : HK$0 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co Inventories, Raw Materials & Components?

Shenzhen Hepalink Pharmaceutical Group Co's inventories, raw materials & components for the quarter that ended in Mar. 2024 was HK$0 Mil.

Shenzhen Hepalink Pharmaceutical Group Co's quarterly raw materials increased from Sep. 2023 (HK$0 Mil) to Dec. 2023 (HK$2,979 Mil) but then declined from Dec. 2023 (HK$2,979 Mil) to Mar. 2024 (HK$0 Mil).

Shenzhen Hepalink Pharmaceutical Group Co's annual raw materials increased from Dec. 2021 (HK$2,134 Mil) to Dec. 2022 (HK$3,433 Mil) but then declined from Dec. 2022 (HK$3,433 Mil) to Dec. 2023 (HK$2,979 Mil).


Shenzhen Hepalink Pharmaceutical Group Co Inventories, Raw Materials & Components Historical Data

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Hepalink Pharmaceutical Group Co Inventories, Raw Materials & Components Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 816.31 1,054.97 2,134.10 3,432.78 2,979.08

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4,058.18 - 2,979.08 -

Shenzhen Hepalink Pharmaceutical Group Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Business Description

Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business and Others. Geographical presence of company is in Hong Kong, United States of America, Europe, Mainland China and Other countries. Majority of the company's revenue comes from USA and Europe.
Executives
Orbimed Capital Llc 2102 Investment manager
Morgan Stanley & Co. International Plc 2105 Underwriter
Morgan Stanley International Holdings Inc. 2201 Interest of corporation controlled by you
Morgan Stanley International Limited 2201 Interest of corporation controlled by you
Morgan Stanley Investments (uk) 2201 Interest of corporation controlled by you
Avict Global Holdings Limited 2101 Beneficial owner
Worldwide Healthcare Trust Plc 2101 Beneficial owner

Shenzhen Hepalink Pharmaceutical Group Co (HKSE:09989) Headlines

No Headlines